Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
9.3M
-
Shares change
-
-406K
-
Total reported value, excl. options
-
$148M
-
Value change
-
-$6.17M
-
Put/Call ratio
-
0.6
-
Number of buys
-
24
-
Number of sells
-
-33
-
Price
-
$15.94
Significant Holders of IMMUNIC, INC. - Common Stock (IMUX) as of Q1 2021
77 filings reported holding IMUX - IMMUNIC, INC. - Common Stock as of Q1 2021.
IMMUNIC, INC. - Common Stock (IMUX) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.3M shares
of 120M outstanding shares and own 7.73% of the company stock.
Largest 10 shareholders include Omega Fund Management, LLC (1.79M shares), FMR LLC (1.19M shares), RTW INVESTMENTS, LP (921K shares), BlackRock Inc. (735K shares), VANGUARD GROUP INC (732K shares), Artal Group S.A. (700K shares), Point72 Asset Management, L.P. (433K shares), Parkman Healthcare Partners LLC (401K shares), Ghost Tree Capital, LLC (265K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (262K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.